Form 4 for OPRX OptimizeRx Corp
Accepted 2025-06-12 00:00:00 ET · period of report 2025-06-11 · accession 0001628280-25-031019 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-06-12 | 2025-06-11 | OPRX | Vos Ellen O'Connor | Dir | A - Grant | $0.00 | +9,868 | 72.6K | +16% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-06-11 | A | A | 9,868 | $0.00 | 72,642 | D | — | — | (F1) Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in full on the earlier of the first anniversary of the date of the grant or the date of the Company's next annual meeting of shareholders. |